Loading organizations...
Loading organizations...
Next-gen precision therapeutics for cardiovascular and neurological disease
HDAX Therapeutics has raised $3.2M across 1 funding round.
HDAX Therapeutics has raised $3.2M in total across 1 funding round.
HDAX Therapeutics has raised $3.2M in total across 1 funding round.
HDAX Therapeutics's investors include David O'Neill, SeedFolio, Toronto Innovation Acceleration Partners.
HDAX Therapeutics has raised $3.2M across 1 funding round. Most recently, it raised $3.2M Seed in September 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 5, 2024 | $3.2M Seed | David O'Neill, SeedFolio, Toronto Innovation Acceleration Partners |